Trial Profile
Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jun 2015
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms PREVENT
- 20 Dec 2011 New trial record